⌘K
Loading ticker…
As of 2026-08-24, Iridex Corp (IRIX) has a 3-month relative strength percentile of 16 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 38. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.0%, relative volume 0.89×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
IRIX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $406K notional.
Held by 2 ETFs · $520K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $406K | — |
| VXFVanguard Extended Market ETF | 0.00% | $114K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IRIX Jan avg: 9.72% median: 5.28% win: 75% σ: 14.99% n: 4 2022-04-12 → 2026-07-31 | IRIX Feb avg: -6.91% median: -5.33% win: 0% σ: 6.31% n: 4 2022-04-12 → 2026-07-31 | IRIX Mar avg: -13.16% median: -17.58% win: 25% σ: 18.72% n: 4 2022-04-12 → 2026-07-31 | IRIX Apr avg: 4.01% median: 1.98% win: 60% σ: 12.98% n: 5 2022-04-12 → 2026-07-31 | IRIX May avg: -11.56% median: -14.74% win: 20% σ: 9.25% n: 5 2022-04-12 → 2026-07-31 | IRIX Jun avg: -5.36% median: -11.11% win: 40% σ: 9.94% n: 5 2022-04-12 → 2026-07-31 | IRIX Jul avg: 5.10% median: -5.99% win: 40% σ: 29.67% n: 5 2022-04-12 → 2026-07-31 | IRIX Aug avg: -7.68% median: -6.81% win: 50% σ: 9.98% n: 4 2022-04-12 → 2026-07-31 (current) | IRIX Sep avg: 4.47% median: -10.12% win: 25% σ: 32.52% n: 4 2022-04-12 → 2026-07-31 | IRIX Oct avg: 0.35% median: -7.29% win: 25% σ: 19.39% n: 4 2022-04-12 → 2026-07-31 | IRIX Nov avg: -1.38% median: -0.51% win: 50% σ: 17.64% n: 4 2022-04-12 → 2026-07-31 | IRIX Dec avg: 1.47% median: 2.02% win: 50% σ: 16.04% n: 4 2022-04-12 → 2026-07-31 |